CoChat

TRIM45 aggravates microglia pyroptosis via Atg5/NLRP3 axis in septic encephalopathy

Open access
Huang, Xuliang, Ye, Changzhou, Zhao, Xinyu, Tong, Yao, Lin, Wen, Huang, Qingqing, Zheng, Yuhao, Wang, Junlu, Zhang, Anqi, Mo, Yunchang · 2023 · Journal of Neuroinflammation

Published version of a preprint

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Background: Neuroinflammation mediated by microglial pyroptosis is an important pathogenic mechanism of septic encephalopathy (SAE). It has been reported that TRIM45 is associated with tumours and inflammatory diseases. However, the role of TRIM45 in SAE and the relationship between TRIM45 and microglial pyroptosis are unknown. In this study, we found that TRIM45 played an important role in regulating microglial pyroptosis and the molecular mechanism. Methods: SAE was induced by intraperitoneal injection of LPS in WT and AAV-shTRIM45 mice. BV2 cells were treated with LPS/ATP in vitro. Cognitive function was assessed by the Morris water maze. Nissl staining was used to evaluate histological and structural lesions. ELISA was used to dectect neuroinflammation. qPCR was used to detect the mRNA levels of inflammatory cytokines, NLRP3, and autophagy genes. Western blotting and immunofluorescence analysis were used to analyse the expression of the proteins. Changes in reactive oxygen species (ROS) in cells were observed by flow cytometry. Changes in mitochondrial membrane potential in BV2 cells were detected by JC-1 staining. Peripheral blood mononuclear cells were extracted from blood by density gradient centrifugation and then used for qPCR, western blotting and flow detection. To further explore the mechanism, we used the overexpression plasmids TRIM45 and Atg5 as well as siRNA-TRIM45 and siRNA-Atg5 to analyse the downstream pathway of NLRP3. The protein and mRNA levels of TRIM45 in peripheral blood mononuclear cells from sepsis patients were examined. Results: Knocking down TRIM45 protected against neuronal damage and cognitive impairment in septic mice. TRIM45 knockdown inhibited microglial pyroptosis and the secretion of inflammatory cytokines in vivo and in vitro, which was mediated by NLRP3/Gsdmd-N activation. Overexpression of TRIM45 could activate NLRP3 and downstream proteins. Further examination showed that TRIM45 regulated the activation of NLRP3 by altering Atg5 and regulating autophagic flux. It was also found that overexpression and knockdown of TRIM45 affected the changes in ROS and mitochondrial membrane potential. Thus, knocking down TRIM45 could reduce microglial pyroptosis, the secretion of proinflammatory cytokines, and neuronal damage and improve cognitive function. In addition, the level of TRIM45 protein in septic patients was increased. There was a positive linear correlation between APACHE II score and TRIM45, between SOFA score and TRIM45. Compared to group GCS > 9, level of TRIM45 were increased in group GCS ≤ 8. Conclusion: TRIM45 plays a key role in neuroinflammation caused by LPS, and the mechanism may involve TRIM45-mediated exacerbation of microglial pyroptosis via the Atg5/NLRP3 axis. Graphical Abstract:

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12974-023-02959-8

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 TRIM45 expression in BV2 cells and the hippocampus is upregulated by LPS. a Experimental design. Six- to eight-week-old male C57BL/6J mice were subjected to Sham treatment or intraperitoneal injection of LPS. The hippocampus was extracted at 24 h. MWM tests were carried out from the 7th to the 11th day. b BV2 cells were treated with LPS (1 µg/mL) for 6 h and then treated with ATP (5 mM) for 30 min. The cells and culture medium were collected for testing. c Distribution and analysis of TRIM45 in the mouse whole-brain atlas. d qRT-PCR analysis of TRIM45 expression in cells induced by LPS + ATP. BV2 (mouse microglia), MA (mouse astrocytes), HT22 (mouse hippocampal neurons) cells; n = 3 per group. e The levels of TRIM45 in BV2 cells were measured by western blotting; n = 3 per group. f Immunofluorescence analysis of TRIM45 expression in BV2 cells. Scale bars, 25 µm; n = 4 per group. g Distribution and scale of TRIM45 in the hippocampal tissue of mice. h Immunofluorescence analysis of TRIM45 expression in different regions of the hippocampus; scale bars, 50 µm. i Immunofluorescence analysis of TRIM45 expression in the hippocampal CA1 region of adult mice subjected to LPS for 24 h; scale bars, 50 µm. j, k TRIM45 expression in the hippocampus was analysed by western blotting and qRT-PCR. Data in d, e, f were analysed by unpaired t test. Data are presented as the mean ± S.E.M. from at least three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001
Fig. 1 TRIM45 expression in BV2 cells and the hippocampus is upregulated by LPS. a Experimental design. Six- to eight-week-old male C57BL/6J mice were subjected to Sham treatment or intraperitoneal injection of LPS. The hippocampus was extracted at 24 h. MWM tests were carried out from the 7th to the 11th day. b BV2 cells were treated with LPS (1 µg/mL) for 6 h and then treated with ATP (5 mM) for 30 min. The cells and culture medium were collected for testing. c Distribution and analysis of TRIM45 in the mouse whole-brain atlas. d qRT-PCR analysis of TRIM45 expression in cells induced by LPS + ATP. BV2 (mouse microglia), MA (mouse astrocytes), HT22 (mouse hippocampal neurons) cells; n = 3 per group. e The levels of TRIM45 in BV2 cells were measured by western blotting; n = 3 per group. f Immunofluorescence analysis of TRIM45 expression in BV2 cells. Scale bars, 25 µm; n = 4 per group. g Distribution and scale of TRIM45 in the hippocampal tissue of mice. h Immunofluorescence analysis of TRIM45 expression in different regions of the hippocampus; scale bars, 50 µm. i Immunofluorescence analysis of TRIM45 expression in the hippocampal CA1 region of adult mice subjected to LPS for 24 h; scale bars, 50 µm. j, k TRIM45 expression in the hippocampus was analysed by western blotting and qRT-PCR. Data in d, e, f were analysed by unpaired t test. Data are presented as the mean ± S.E.M. from at least three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001CC BY · PubMed Central
Fig. 2 TRIM45 promotes NLRP3 signalling activation in BV2 cells induced by LPS + ATP. a Volcano graph of the control group and transfected group. The blue dots represent low expression, while the red dots represent high expression. b Pathway analysis of the enriched DEGs in GSE76328. c Gene set enrichment analysis of GSE76328. d Western blot analysis of pyroptosis-related proteins and TRIM45 in BV2 cells. e qRT-PCR analysis of IL-1β and IL-18 mRNA levels in BV2 cells; n = 3 per group. f BV2 cell secretion of IL-1β was determined by ELISAs; n = 3 per group. g Flow cytometry was used to analyse BV2 pyroptosis; n = 3 per group. h, i Immunofluorescence analysis of NLRP3, Gsdmd, and IL-1β levels in BV2 cells. Scale bars, 25 μm; n = 3 per group. Data in e–i were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data are presented as the mean ± S.E.M. from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001
Fig. 2 TRIM45 promotes NLRP3 signalling activation in BV2 cells induced by LPS + ATP. a Volcano graph of the control group and transfected group. The blue dots represent low expression, while the red dots represent high expression. b Pathway analysis of the enriched DEGs in GSE76328. c Gene set enrichment analysis of GSE76328. d Western blot analysis of pyroptosis-related proteins and TRIM45 in BV2 cells. e qRT-PCR analysis of IL-1β and IL-18 mRNA levels in BV2 cells; n = 3 per group. f BV2 cell secretion of IL-1β was determined by ELISAs; n = 3 per group. g Flow cytometry was used to analyse BV2 pyroptosis; n = 3 per group. h, i Immunofluorescence analysis of NLRP3, Gsdmd, and IL-1β levels in BV2 cells. Scale bars, 25 μm; n = 3 per group. Data in e–i were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data are presented as the mean ± S.E.M. from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001CC BY · PubMed Central
Fig. 3 TRIM45 regulates autophagy proteins associated with NLRP3. a qRT-PCR analysis of p62, Atg5, and beclin1 mRNA levels in BV2 cells; n = 3 per group. b The autophagy proteins p62, beclin1, Atg5 and LC3 in BV2 cells were measured by western blotting. c Changes in ROS in BV2 cells in the different groups; n = 3 per group. d JC-1 staining to detect mitochondrial membrane potential and cellular morphology was examined by a phase-contrast microscope. (scale bar = 75 μm); n ≥ 3 per group. Data in a, c, d were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data are presented as the mean ± S.E.M. from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001
Fig. 3 TRIM45 regulates autophagy proteins associated with NLRP3. a qRT-PCR analysis of p62, Atg5, and beclin1 mRNA levels in BV2 cells; n = 3 per group. b The autophagy proteins p62, beclin1, Atg5 and LC3 in BV2 cells were measured by western blotting. c Changes in ROS in BV2 cells in the different groups; n = 3 per group. d JC-1 staining to detect mitochondrial membrane potential and cellular morphology was examined by a phase-contrast microscope. (scale bar = 75 μm); n ≥ 3 per group. Data in a, c, d were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data are presented as the mean ± S.E.M. from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001CC BY · PubMed Central
Fig. 4 TRIM45 regulates Atg5 based on its E3 ubiquitin ligase activity. a Western blot analysis of Atg5 expression in BV2 cells in response to different interventions. b BV2 cells with TRIM45 knockdown or control cells were treated with cycloheximide (CHX) for 0, 2 and 4 h. c BV2 cells were immunoprecipitated with IgG and anti-Atg5 antibodies, and the expression of TRIM45 and Atg5 was detected by western blotting. d Protein confidence analysis of Atg5 and TRIM45 was performed by high-throughput interactive group (TRIM45 (green), Atg5 (blue)). e BV2 cells were transfected with HA-TRIM45 for 48 h. BV2 cells were immunoprecipitated with an anti-Atg5 antibody and then subjected to western blot analysis with an anti-NLRP3 antibody. f Co-IP analysis of Atg5 ubiquitination in BV2 cells. The cell extracts were collected for IP with anti-Atg5 beads, followed by IP analysis with the indicated antibodies. g HEK293T cells were transfected with TRIM45 and HA-tagged ubiquitin plasmids with or without LPS + ATP treatment. The cell extracts were collected for IP with anti-Atg5 beads, followed by IP analysis with the indicated antibodies. h, i HEK293T cells were transfected with plasmids TRIM45 and HA-tagged k63 or k48 ubiquitin with or without LPS + ATP treatment. The cell extracts were collected for IP with anti-Atg5 beads, followed by IP analysis with the indicated antibodies
Fig. 4 TRIM45 regulates Atg5 based on its E3 ubiquitin ligase activity. a Western blot analysis of Atg5 expression in BV2 cells in response to different interventions. b BV2 cells with TRIM45 knockdown or control cells were treated with cycloheximide (CHX) for 0, 2 and 4 h. c BV2 cells were immunoprecipitated with IgG and anti-Atg5 antibodies, and the expression of TRIM45 and Atg5 was detected by western blotting. d Protein confidence analysis of Atg5 and TRIM45 was performed by high-throughput interactive group (TRIM45 (green), Atg5 (blue)). e BV2 cells were transfected with HA-TRIM45 for 48 h. BV2 cells were immunoprecipitated with an anti-Atg5 antibody and then subjected to western blot analysis with an anti-NLRP3 antibody. f Co-IP analysis of Atg5 ubiquitination in BV2 cells. The cell extracts were collected for IP with anti-Atg5 beads, followed by IP analysis with the indicated antibodies. g HEK293T cells were transfected with TRIM45 and HA-tagged ubiquitin plasmids with or without LPS + ATP treatment. The cell extracts were collected for IP with anti-Atg5 beads, followed by IP analysis with the indicated antibodies. h, i HEK293T cells were transfected with plasmids TRIM45 and HA-tagged k63 or k48 ubiquitin with or without LPS + ATP treatment. The cell extracts were collected for IP with anti-Atg5 beads, followed by IP analysis with the indicated antibodiesCC BY · PubMed Central
Fig. 5 TRIM45 regulates the NLRP3 pathway in an Atg5-dependent manner. a, b Western blot analysis and quantification of NLRP3, Gsdmd-N, Atg5 and IL-1β levels in BV2 cells transfected with siTRIM45 or HA-TRIM45 and stimulated by LPS + ATP; n = 3 per group. c BV2 cells were infected with siTRIM45 and Flag-Atg5; n = 4 per group. d BV2 cells were infected with HA-TRIM45 and siAtg5; n = 4 per group. e, f Statistical analysis of Figures c and d. g, h Flow cytometry was used to analyse BV2 pyroptosis; n = 3 per group. Data in a, b, h were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data in c, d were analysed by unpaired t test. Data are presented as the mean ± S.E.M. from at least three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001
Fig. 5 TRIM45 regulates the NLRP3 pathway in an Atg5-dependent manner. a, b Western blot analysis and quantification of NLRP3, Gsdmd-N, Atg5 and IL-1β levels in BV2 cells transfected with siTRIM45 or HA-TRIM45 and stimulated by LPS + ATP; n = 3 per group. c BV2 cells were infected with siTRIM45 and Flag-Atg5; n = 4 per group. d BV2 cells were infected with HA-TRIM45 and siAtg5; n = 4 per group. e, f Statistical analysis of Figures c and d. g, h Flow cytometry was used to analyse BV2 pyroptosis; n = 3 per group. Data in a, b, h were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data in c, d were analysed by unpaired t test. Data are presented as the mean ± S.E.M. from at least three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001CC BY · PubMed Central
Fig. 6 Inhibiting TRIM45 can reduce neuronal injury in SAE. a BV2 cells were treated with siTRIM45, cocultured with neurons in a transwell system and subjected to LPS + ATP. b Levels of Caspase-1 and Cl-Caspase-1 in HT22 cells were measured by western blotting; n = 3 per group. c Immunofluorescence analysis of Cl-Caspase-1 levels in HT22 cells. Scale bars, 20 um; n = 3 per group. d Apoptosis in HT22 cells was detected by flow cytometry; n = 3 per group. e Neuronal damage in the hippocampal region was assessed by Nissl staining. Scale bar, 50 µm; n = 3 per group. Data in b, d, e were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data in c were analysed by unpaired t test. Data are presented as the mean ± S.E.M. from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001
Fig. 6 Inhibiting TRIM45 can reduce neuronal injury in SAE. a BV2 cells were treated with siTRIM45, cocultured with neurons in a transwell system and subjected to LPS + ATP. b Levels of Caspase-1 and Cl-Caspase-1 in HT22 cells were measured by western blotting; n = 3 per group. c Immunofluorescence analysis of Cl-Caspase-1 levels in HT22 cells. Scale bars, 20 um; n = 3 per group. d Apoptosis in HT22 cells was detected by flow cytometry; n = 3 per group. e Neuronal damage in the hippocampal region was assessed by Nissl staining. Scale bar, 50 µm; n = 3 per group. Data in b, d, e were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data in c were analysed by unpaired t test. Data are presented as the mean ± S.E.M. from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001CC BY · PubMed Central
Fig. 7 Knockdown of TRIM45 can improve cognitive impairment and may be a target for treating patients with sepsis. a The levels of NLRP3, Gsdmd-N and TRIM45 in the mouse hippocampus were measured by western blotting; n ≥ 3 per group. b The numbers of Gsdmd+/DAPI and NLRP3+/DAPI positive cells in the hippocampus were measured by immunofluorescence staining. Scale bar, 10 µm; n = 3 per group. c The levels of secreted IL-6 and TNF-α were determined by flow cytometry; n ≥ 3 per group. d The levels of secreted IL-1β and IL-18 were determined by ELISA; n = 3 per group. e Flow cytometric analysis of M1 (CD86+) mononuclear macrophages in the serum of different groups of mice; n = 3 per group. f 7-day survival rates of mice induced by LPS. n = 12 per group. #P < 0.05 Sham vs. LPS, *P < 0.05 LPS vs. LPS + AAV-TRIM45. g Morris experiment and corresponding statistical analysis; n ≥ 8 per group. h The levels of TRIM45 in peripheral blood monocytes were measured by western blotting (c: control, s: sepsis); n = 5 per group. i Relation between TRIM45 and the GCS score; Group 1: GCS score of patients ≤ 8, n = 26; Group 2: GCS score of patients > 9, n = 6. J Correlation between TRIM45 expression and Acute Physiologic and Chronic Health Evaluation II scores in septic patients (R2 = 0.9342, P < 0.0001); n = 44. k Correlation between TRIM45 expression and SOFA scores in septic patients (R2 = 0.3365, P < 0.0001); n = 44. Data in f were assessed by the Kaplan–Meier log-rank test. Data in j, k were analysed by Spearman correlation test. Data in i were analysed by unpaired t test, and others were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data are presented as the mean ± S.E.M. from at least three independent experiments. n.s. for P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001
Fig. 7 Knockdown of TRIM45 can improve cognitive impairment and may be a target for treating patients with sepsis. a The levels of NLRP3, Gsdmd-N and TRIM45 in the mouse hippocampus were measured by western blotting; n ≥ 3 per group. b The numbers of Gsdmd+/DAPI and NLRP3+/DAPI positive cells in the hippocampus were measured by immunofluorescence staining. Scale bar, 10 µm; n = 3 per group. c The levels of secreted IL-6 and TNF-α were determined by flow cytometry; n ≥ 3 per group. d The levels of secreted IL-1β and IL-18 were determined by ELISA; n = 3 per group. e Flow cytometric analysis of M1 (CD86+) mononuclear macrophages in the serum of different groups of mice; n = 3 per group. f 7-day survival rates of mice induced by LPS. n = 12 per group. #P < 0.05 Sham vs. LPS, *P < 0.05 LPS vs. LPS + AAV-TRIM45. g Morris experiment and corresponding statistical analysis; n ≥ 8 per group. h The levels of TRIM45 in peripheral blood monocytes were measured by western blotting (c: control, s: sepsis); n = 5 per group. i Relation between TRIM45 and the GCS score; Group 1: GCS score of patients ≤ 8, n = 26; Group 2: GCS score of patients > 9, n = 6. J Correlation between TRIM45 expression and Acute Physiologic and Chronic Health Evaluation II scores in septic patients (R2 = 0.9342, P < 0.0001); n = 44. k Correlation between TRIM45 expression and SOFA scores in septic patients (R2 = 0.3365, P < 0.0001); n = 44. Data in f were assessed by the Kaplan–Meier log-rank test. Data in j, k were analysed by Spearman correlation test. Data in i were analysed by unpaired t test, and others were analysed by one-way ANOVA followed by Dunnett’s post hoc test. Data are presented as the mean ± S.E.M. from at least three independent experiments. n.s. for P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 60

Metadata

Authors
Huang, X., Ye, C., Zhao, X., Tong, Y., Lin, W., Huang, Q., Zheng, Y., Wang, J., Zhang, A., & Mo, Y.
Affiliations
  • First Affiliated Hospital of Wenzhou Medical University (CN)
  • Southern Medical University (CN)
Corresponding author
  • Zhang, Anqi
  • Mo, Yunchang
Venue
Journal of Neuroinflammation
Published
2023-11-30
Volume
20
Issue
1
Pages
284-284
ISSN
1742-2094 (ISSN-L)
OpenAlex
W4389199632
Cited by
60
References
56
Citations by year
2026: 26 · 2025: 21 · 2024: 13
FWCI
5.33
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81603685)
  • Wenzhou Municipal Science and Technology Bureau
  • Natural Science Foundation of Zhejiang Province (81603685, LY22H150003, LQ21H150007)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords
microglial pyroptosis, sepsis-associated encephalopathy, NLRP3 inflammasome, ATG5, autophagy, GSDMD-N, neuroinflammation, autophagic flux, reactive oxygen species, mitochondrial membrane potential, cognitive impairment, sepsis, peripheral blood mononuclear cells, LPS-induced neuroinflammation
MeSH terms
Pyroptosis, Autophagy-Related Protein 5, NLR Family, Pyrin Domain-Containing 3 Protein, Neuroinflammatory Diseases, Animals, Humans, Leukocytes, Mononuclear, Lipopolysaccharides, Repressor Proteins, RNA, Messenger, Cytokines, Reactive Oxygen Species, Microglia, RNA, Small Interfering, Mice, Inflammasomes, Sepsis-Associated Encephalopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TRIM45 aggravates microglia pyroptosis via Atg5/NLRP3 axis in septic encephalopathy. https://app.cochat.ai/papers/10.1186/s12974-023-02959-8
The paper
Huang, X., Ye, C., Zhao, X., Tong, Y., Lin, W., Huang, Q., Zheng, Y., Wang, J., Zhang, A., & Mo, Y. (2023). TRIM45 aggravates microglia pyroptosis via Atg5/NLRP3 axis in septic encephalopathy. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-023-02959-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.